Using smartphones to help people recover from opioid addiction
SOAR: Smartphones for Opioid Addiction Recovery
This study is testing a smartphone tool that helps people in treatment for opioid use disorder by predicting their chances of using opioids again in the next week, making it easier for them to stay on track with their recovery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11162310 on NIH RePORTER |
What this research studies
This research focuses on developing a smartphone-based tool to predict and reduce illicit opioid use among individuals undergoing treatment for Opioid Use Disorder (OUD). By utilizing a quick assessment that estimates the likelihood of opioid reuse within the next week, the project aims to enhance treatment adherence and outcomes. The tool has shown promising results in pilot tests, demonstrating high retention and compliance rates among users. The approach leverages existing smartphone technology, making it accessible for many patients in treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Opioid Use Disorder who are currently receiving treatment and have access to a smartphone.
Not a fit: Patients who are not currently undergoing treatment for opioid addiction or do not have access to a smartphone may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve recovery rates for individuals struggling with opioid addiction by providing timely interventions based on predictive analytics.
How similar studies have performed: Previous research has shown success with similar smartphone-based interventions in addiction treatment, indicating a promising avenue for this approach.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Glimcher, Paul W — New York University School of Medicine
- Study coordinator: Glimcher, Paul W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.